Gastrointestinal Diseases

Feb 17, 2021| Posted in: Cancers, Gastrointestinal Diseases

Overview of Squamous Cell Carcinoma of the Anal Canal

Lance Leopold, MD, Group Vice President, Immuno-Oncology, at…
Feb 12, 2021| Posted in: Cancers, Drug Development, Gastrointestinal Diseases, Treatment

Incyte’s Investigational Drug Therapy for Squamous Cell Carcinoma of the Anal Canal

Lance Leopold, MD, Group Vice President, Immuno-Oncology, at…
Feb 9, 2021| Posted in: Cancers, Drug Development, Gastrointestinal Diseases, Treatment

Efficacy of Retifanlimab to Treat Squamous Cell Carcinoma of the Anal Canal

Lance Leopold, MD, Group Vice President, Immuno-Oncology, at…
Feb 8, 2021| Posted in: Drug Development, Gastrointestinal Diseases, Metabolic Disorders, Regulations

Orphan Drug Incentives From the FDA

Ron Cooper, President and CEO of Albireo Pharma,…
Dec 1, 2020| Posted in: Congenital And Genetic Conditions, Expert Perspectives, Gastrointestinal Diseases, Metabolic Disorders

PFIC Overview

Ron Cooper, President and CEO of Albireo Pharma…

CME Program: Gaucher Disease Highlights from WORLDSymposium 2020

Neal Weinreb, MD, FACP highlights the latest information about Gaucher disease from WORLDSymposium and provides expert analysis of its clinical relevance to help health care providers better care for patients with this rare disease.

CME Program: Fabry Disease Highlights from WORLDSymposium 2020

Ozlem Goker-Alpan, MD highlights the latest Fabry disease information from the WORLDSymposium and provides expert analysis of its clinical relevance for members of the care team in order to help them care for patients with this rare disease.

CME Program: Mucopolysaccharidoses (MPSs) Highlights from WORLDSymposium 2020

Barbara K. Burton, MD highlights the latest information about MPSs from WORLDSymposium and provides expert analysis of its clinical relevance for members of the care team in order to help them care for patients with these rare diseases.

Gastrointestinal Diseases

Topics